Abiopharma

New Form SCHEDULE 13D/A - Oncology Institute, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085013 Size: 37 KB

New Form 3 - Perspective Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0000950170-25-113244 Size: 19 KB

New Form SCHEDULE 13D/A - American Bitcoin Corp. /DE/ Filed: 2025-09-05 AccNo: 0001104659-25-087792 Size: 18 KB

Cline Christopher R. 🔴 sold 573 shares of Travere Therapeutics, Inc. (TVTX) at $19.71 Transaction Date: Sep 03, 2025 | Filing ID: 023786

Artelo Biosciences Announces Closing of $3.0 Million Public Offering

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Artelo Biosciences Announces Closing of $3.0 Million Public Offering

Gyre Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Coherent Joins LLNL’s STARFIRE Diode Technology Working Group to Advance Inertial Fusion Energy

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

New Form 144 - Perimeter Solutions, Inc. Filed: 2025-09-05 AccNo: 0001950047-25-006777 Size: 4 KB

Martinez Maria E 🟢 acquired 75.0K shares (1 derivative) of Perspective Therapeutics, Inc. (CATX) at $3.38 Transaction Date: Sep 03, 2025 | Filing ID: 113243

New Form 3 - Perspective Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0000950170-25-113242 Size: 20 KB

New Form 144 - BeOne Medicines Ltd. Filed: 2025-09-05 AccNo: 0001950047-25-006771 Size: 4 KB